New! View global litigation for patent families

WO2004006863A3 - Therapeutic devices for patterned cell growth - Google Patents

Therapeutic devices for patterned cell growth

Info

Publication number
WO2004006863A3
WO2004006863A3 PCT/US2003/022361 US0322361W WO2004006863A3 WO 2004006863 A3 WO2004006863 A3 WO 2004006863A3 US 0322361 W US0322361 W US 0322361W WO 2004006863 A3 WO2004006863 A3 WO 2004006863A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
devices
therapeutic
anti
inflammatory
agents
Prior art date
Application number
PCT/US2003/022361
Other languages
French (fr)
Other versions
WO2004006863A2 (en )
Inventor
Kristine Schmalenberg
Kathryn E Uhrich
Original Assignee
Kristine Schmalenberg
Kathryn E Uhrich
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063Periodont
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets

Abstract

The invention provides therapeutic devices comprising a polymeric anti-inflammatory agent that biodegrades to release anti-inflammatory agents. The therapeutic devices are useful for repair and regeneration of a variety of injured tissues.
PCT/US2003/022361 2002-07-17 2003-07-17 Therapeutic devices for patterned cell growth WO2004006863A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US39662802 true 2002-07-17 2002-07-17
US60/396,628 2002-07-17

Publications (2)

Publication Number Publication Date
WO2004006863A2 true WO2004006863A2 (en) 2004-01-22
WO2004006863A3 true true WO2004006863A3 (en) 2004-08-26

Family

ID=30116045

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/022361 WO2004006863A3 (en) 2002-07-17 2003-07-17 Therapeutic devices for patterned cell growth

Country Status (2)

Country Link
US (2) US20040096476A1 (en)
WO (1) WO2004006863A3 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108070B2 (en) 2006-09-13 2015-08-18 Polymerix Corporation Active agents and their oligomers and polymers
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985415B2 (en) * 1997-09-10 2011-07-26 Rutgers, The State University Of New Jersey Medical devices employing novel polymers
US7122615B1 (en) * 1998-09-10 2006-10-17 Rutgers, The State University Of New Jersey Polyanhydrides with therapeutically useful degradation products
US6486214B1 (en) * 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US20040038948A1 (en) * 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
EP1309354A2 (en) * 2000-07-27 2003-05-14 Rutgers, The State University Therapeutic polyesters and polyamides
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US20050208093A1 (en) 2004-03-22 2005-09-22 Thierry Glauser Phosphoryl choline coating compositions
US9561309B2 (en) 2004-05-27 2017-02-07 Advanced Cardiovascular Systems, Inc. Antifouling heparin coatings
FI20045223A (en) * 2004-06-15 2005-12-16 Bioretec Oy Multi-functional composite and biodegradable surgical implant comprising said composite
WO2006044904A3 (en) * 2004-10-15 2006-08-24 Univ Vanderbilt Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering
JP2008545695A (en) 2005-05-23 2008-12-18 ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー Rapid degradation polymer
EP1915165B1 (en) * 2005-08-12 2014-07-02 Brown University Topographical templating of polymeric materials using cellular morphology
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corp. Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8318973B2 (en) * 2005-10-21 2012-11-27 Bezwada Biomedical, Llc Functionalized sinapic acid and methyl sinapate
WO2007082088A3 (en) * 2006-01-12 2008-01-24 Histogenics Corp Method for repair and reconstruction of ruptured ligaments or tendons and for treatment of ligament and tendon injuries
EP2032614A2 (en) 2006-06-06 2009-03-11 Rutgers, The State University Of New Jersey Iodinated polymers
US8685430B1 (en) 2006-07-14 2014-04-01 Abbott Cardiovascular Systems Inc. Tailored aliphatic polyesters for stent coatings
US7713541B1 (en) * 2006-11-21 2010-05-11 Abbott Cardiovascular Systems Inc. Zwitterionic terpolymers, method of making and use on medical devices
WO2008128193A1 (en) 2007-04-12 2008-10-23 Rutgers, The State University Of New Jersey Biodegradable polyanhydrides with natural bioactive molecules
US8217134B2 (en) * 2007-08-30 2012-07-10 Bezwada Biomedical, Llc Controlled release of biologically active compounds
US8026285B2 (en) 2007-09-04 2011-09-27 Bezwada Biomedical, Llc Control release of biologically active compounds from multi-armed oligomers
US8048980B2 (en) * 2007-09-17 2011-11-01 Bezwada Biomedical, Llc Hydrolysable linkers and cross-linkers for absorbable polymers
US8053591B2 (en) 2007-09-26 2011-11-08 Bezwada Biomedical, Llc Functionalized biodegradable triclosan monomers and oligomers for controlled release
US8367747B2 (en) 2008-05-23 2013-02-05 Bezwada Biomedical, Llc Bioabsorbable polymers from bioabsorbable polyisocyanates and uses thereof
KR101018894B1 (en) * 2008-08-27 2011-03-04 근화제약주식회사 Pharmaceutical compositions, formulations and absorption of Talniflumate extended release tablets
US8741317B2 (en) 2010-08-19 2014-06-03 Rutgers, The State University Of New Jersey Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
JP5776162B2 (en) * 2010-10-13 2015-09-09 東洋製罐グループホールディングス株式会社 For adherent cells culture vessel, and a manufacturing method of adherent cells for culture vessel
WO2017062417A1 (en) * 2015-10-05 2017-04-13 The Trustees Of Princetion University Scaffolds for neural tissue and uses thereof
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
WO2014194055A1 (en) 2013-05-29 2014-12-04 Rutgers, The State University Of New Jersey Antioxidant-based poly(anhydride-esters)
WO2016118349A1 (en) * 2015-01-21 2016-07-28 The Trustees Of Princeton University Patterning of fragile or non-planar surfaces for cell alignment

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886870A (en) * 1984-05-21 1989-12-12 Massachusetts Institute Of Technology Bioerodible articles useful as implants and prostheses having predictable degradation rates
US5264540A (en) * 1992-07-20 1993-11-23 Ethicon, Inc. Aromatic polyanhydrides
US6123956A (en) * 1997-07-10 2000-09-26 Keith Baker Methods for universally distributing therapeutic agents to the brain
WO2000066730A2 (en) * 1999-04-30 2000-11-09 University Of Medicine And Dentistry Of New Jersey Robert Wood Johnson Medical School Laminin 2 and methods for its use
US6171610B1 (en) * 1998-04-24 2001-01-09 University Of Massachusetts Guided development and support of hydrogel-cell compositions
US6280772B1 (en) * 1995-06-30 2001-08-28 Baylor University Polyester/carboxylic acid composite materials
US6365149B2 (en) * 1999-06-30 2002-04-02 Ethicon, Inc. Porous tissue scaffoldings for the repair or regeneration of tissue

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062855A (en) * 1971-09-27 1977-12-13 University Of Washington Synthetic polymers furnishing controlled release of a biologically active component during degradation
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4298595A (en) * 1978-12-20 1981-11-03 Dynapol Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
US4906474A (en) * 1983-03-22 1990-03-06 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4891225A (en) * 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4888176A (en) * 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules
FR2590262B1 (en) * 1985-10-02 1992-06-12 Sandoz Sa New polyanhydrides, their preparation and their use as pharmacologically active matrix
US5160745A (en) * 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US4757128A (en) * 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US5721131A (en) * 1987-03-06 1998-02-24 United States Of America As Represented By The Secretary Of The Navy Surface modification of polymers with self-assembled monolayers that promote adhesion, outgrowth and differentiation of biological cells
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US4857311A (en) * 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
US5259968A (en) * 1988-02-29 1993-11-09 Exxon Chemical Patents Inc. Dispersant additive comprising the reaction product of a polyanhydride and a mannich condensation product
US4868274A (en) * 1988-05-23 1989-09-19 Hoechst Celanese Corp. Polyanhydride from carboxy aryloxy alkanoic acid
US5356630A (en) * 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US4999417A (en) * 1989-03-30 1991-03-12 Nova Pharmaceutical Corporation Biodegradable polymer compositions
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US4997904A (en) * 1989-08-25 1991-03-05 Nova Pharmaceutical Corporation Aromatic polyanhydride compositions
US5032216A (en) * 1989-10-20 1991-07-16 E. I. Du Pont De Nemours And Company Non-photographic method for patterning organic polymer films
US5660851A (en) * 1989-12-26 1997-08-26 Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem Ocular inserts
JPH06501448A (en) * 1989-12-26 1994-02-17
US5317079A (en) * 1990-01-19 1994-05-31 Nova Pharmaceutical Corporation Fatty acid terminated polyanhydride
US5290494A (en) * 1990-03-05 1994-03-01 Board Of Regents, The University Of Texas System Process of making a resorbable implantation device
US5175235A (en) * 1990-06-04 1992-12-29 Nova Pharmaceutical Corporation Branched polyanhydrides
US5082925A (en) * 1990-08-16 1992-01-21 Ethicon, Inc. Homopolymers and copolymers of salicylate lactones
CA2096144A1 (en) * 1990-11-19 1992-05-20 Jean M.J. Frechet Hyperbranched polyesters and polyamides
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
WO1995005083A1 (en) * 1993-08-13 1995-02-23 Smith & Nephew Richards Inc Microporous polymeric foams and microtextured surfaces
US5776748A (en) * 1993-10-04 1998-07-07 President And Fellows Of Harvard College Method of formation of microstamped patterns on plates for adhesion of cells and other biological materials, devices and uses therefor
US5512131A (en) * 1993-10-04 1996-04-30 President And Fellows Of Harvard College Formation of microstamped patterns on surfaces and derivative articles
GB9400163D0 (en) * 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
US5902110A (en) * 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
JP4341986B2 (en) * 1996-02-15 2009-10-14 インターフェイス バイオロジックス インコーポレイテッド Bioresponsive, pharmacologically active polymers and articles made therefrom
US5902599A (en) * 1996-02-20 1999-05-11 Massachusetts Institute Of Technology Biodegradable polymer networks for use in orthopedic and dental applications
US5958911A (en) * 1996-11-05 1999-09-28 The Research Foundation Of State University Of New York Method of relieving inflammation by using 5-alkylsulfonylsalicylanilides
US5891477A (en) * 1997-03-28 1999-04-06 Biohybrid Technologies, Inc. Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device
US6486214B1 (en) * 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US5937758A (en) * 1997-11-26 1999-08-17 Motorola, Inc. Micro-contact printing stamp
US6153212A (en) * 1998-10-02 2000-11-28 Guilford Pharmaceuticals Inc. Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
US20040038948A1 (en) * 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
US6602915B2 (en) * 2000-07-27 2003-08-05 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
EP1309354A2 (en) * 2000-07-27 2003-05-14 Rutgers, The State University Therapeutic polyesters and polyamides
WO2003065928A9 (en) * 2002-02-07 2004-05-27 Univ Rutgers Therapeutic polyesters and polyamides

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886870A (en) * 1984-05-21 1989-12-12 Massachusetts Institute Of Technology Bioerodible articles useful as implants and prostheses having predictable degradation rates
US5264540A (en) * 1992-07-20 1993-11-23 Ethicon, Inc. Aromatic polyanhydrides
US6280772B1 (en) * 1995-06-30 2001-08-28 Baylor University Polyester/carboxylic acid composite materials
US6123956A (en) * 1997-07-10 2000-09-26 Keith Baker Methods for universally distributing therapeutic agents to the brain
US6171610B1 (en) * 1998-04-24 2001-01-09 University Of Massachusetts Guided development and support of hydrogel-cell compositions
WO2000066730A2 (en) * 1999-04-30 2000-11-09 University Of Medicine And Dentistry Of New Jersey Robert Wood Johnson Medical School Laminin 2 and methods for its use
US6365149B2 (en) * 1999-06-30 2002-04-02 Ethicon, Inc. Porous tissue scaffoldings for the repair or regeneration of tissue

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108070B2 (en) 2006-09-13 2015-08-18 Polymerix Corporation Active agents and their oligomers and polymers
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Also Published As

Publication number Publication date Type
US20100291181A1 (en) 2010-11-18 application
WO2004006863A2 (en) 2004-01-22 application
US20040096476A1 (en) 2004-05-20 application

Similar Documents

Publication Publication Date Title
WO2004006906A3 (en) Methods for the treatment of neoplasms
WO2003051294A3 (en) Mitocidal compositions and methods
WO2005065645A3 (en) Donepezil formulations
WO2003099339A1 (en) Decoy composition for treating and preventing inflammatory disease
WO2005000332A3 (en) Therapeutic agent for soft tissue sarcoma
WO2003082188A3 (en) Methods and drug delivery systems for the treatment of orofacial diseases
WO2005001078A3 (en) Regeneration and repair of neural tissue using postpartum-derived cells
CA2458853A1 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003033004A1 (en) Agents for treating inflammatory bowel diseases
WO2003051276B1 (en) Therapeutic heterocycles
WO2006096793A3 (en) Medical implants
WO2002067895A3 (en) Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
WO2005011736A1 (en) Drug for preventing and/or treating alzheimer’s disease
WO2001068066A3 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
WO2007002390A3 (en) Compositions and methods for modulation of smn2 splicing
WO2004060270A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003051387A1 (en) Remedies and/or preventives for conformational diseases
WO2003005971A8 (en) Tetracycline compounds having target therapeutic activities
WO2001047526A1 (en) Remedies for external use for allergic skin diseases
WO2005044199A3 (en) Combination of proton pump inhibitor and sleep aid
GB0222969D0 (en) Improvements relating to surgical protective devices
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
GB0116247D0 (en) Surgical techniques and devices

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct app. not ent. europ. phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP